Prepping for the 2006-2007 flu season

Article

The CDC's Advisory Committee on Immunization Practices has issued an updated set of influenza recommendations for the coming influenza season (MMWR "Recommendations and Reports," July 28). Principal changes from last year include:

Speaking of the possibility of a flu vaccine shortage: The Food and Drug Administration has approved four manufacturers' formulation of a flu vaccine for the 2006-2007 flu season. Those four (GlaxoSmithKline, Chiron, MedImmune, and Sanofi Pasteur) report that they expect to produce a total of 100 million doses for the coming season. But, as the FDA said in a statement, that projection could change as manufacturing continues.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
Surge in pediatric Mycoplasma pneumoniae hospitalizations reported in 2024: Image Credit: © Pixel-Shot - stock.adobe.com.

Surge in pediatric Mycoplasma pneumoniae hospitalizations reported in 2024

Morgan Ebert, Managing Editor
June 26th 2025
Article

Mycoplasma pneumoniae caused 1 in 2 pediatric pneumonia hospitalizations in 2024, with sharp increases seen across all age groups, according to a recent CDC MMWR report.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

ACIP: New members meeting June 26,26; AAP liaisons not participating | Image Credit: © weyo - © weyo - stock.adobe.com.

ACIP: New members meeting June 25-26; AAP liaisons not participating

Joshua Fitch, Senior Editor
June 25th 2025
Article

The American Academy of Pediatrics will continue to hold its own childhood vaccine schedule, as it has since the 1930s.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

Joshua Fitch, Senior Editor
June 13th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age | Image credit: Contemporary Pediatrics

FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age

Joshua Fitch, Senior Editor
June 12th 2025
Article

Glecaprevir/pibrentasvir was a "highly efficacious treatment for people with acute HCV," with 96.2% of patients analyzed having sustained virological response 12 weeks post-treatment.

© 2025 MJH Life Sciences

All rights reserved.